Slingshot members are tracking this event:

Celgene's (CELG) VIDAZA Cleared By European Commission for New Indication to Include Adult Patients 65 Years and Older with Acute Myeloid Leukemia Not Eligible for Hematopoietic Stem Cell Transplantation

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 30, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Vidaza, Ema, Acute Myeloid Leukemia, Hematopoietic Stem Cell Transplantation, Hsct